SEC Form 4 · accession 0001965585-26-000006
Serina Therapeutics, Inc. · SER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Farrell Simon
Director
Period of report
Jul 22, 2026
Accepted (ET)
Jul 23, 2026 · 6:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001708599
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.17 | Jul 22, 2026 | A | 30,500 | A | — | Jul 22, 2036 | Common Stock | 30,500 | 30,500 | D |
Explanation of responses
- F1The stock options vest in substantially equal yearly installments beginning on the first anniversary of the grant date such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.